blog

With Major Government Support, Biotech and Life Sciences Likely Heading Into Innovation Renaissance

Read this week’s blog post to see how Biden’s new executive order may spark biotech, healthcare and life sciences innovations and startups.

Azeem Zeekrya, Associate Director, Scientific Communications | October 24, 2022

Biotech | Life Sciences | Current Affairs

Zoomedia & Harris D. McKinney Join Forces

For the last 16 years, Zoomedia has been leading interactive communications for the life sciences. Today, we are delighted to announce that we have joined forces with Harris D. McKinney, a leading life science marketing and brand communications agency.

Barbara Lavery | June 11, 2014

Marketing | Press Releases | Public Relations | Scientific Communication | HDMZ | Biotech | Life Sciences | Website Development

Deliver a Successful Investor Presentation

Does your investor presentation clearly articulate your passion, commitment and value in 20 minutes or less? The development and delivery of a presentation plays a critical part in getting the attention you want and deserve. Every company has a different story to tell, but most of the time the presentations are in the same format, in the same room, and to the same people. Our team has had the privilege of watching and developing biotech company presentations for over 15 years.

HDMZ Staff | March 25, 2013

Corporate Communications | Investor Relations | Investor Presentations | Biotech | Pharma

Networked & Personalized - the future of biotech?

During BIO2012 last week, Ernst & Young presented their annual Beyond Borders report on the state of the biotech industry. Several themes are covered in the report but the underlying trend is a much broader discussion and movement towards open sharing of data and collaboration across academia, industry, patient advocacy groups and payors. This "networked innovation" aligns biotech with high tech's much broader use of data and personalized targeting that we see at work in social networks and online advertsing every day and has enormous opportunity to increase timelines and success rates in drug development.

Barbara Lavery | June 25, 2012

Biotech | Personalized Medicine | Pharma

Spring time = launch time!

With FDA and EMA reviews and decisions pending for many of our clients we are working on global launch strategies to support commercial and corporate teams as they gear up for product approval across multiple countries.

Barbara Lavery | April 3, 2012

Communication Plan | Biotech | Pharma | Social Media | Website Development

Making the Most of Your 15 Minutes of Fame

Having watched and helped develop biotech company presentations for many years, I can recommend some basic rules of play that can help make your presentation the one that stands out. Every company has a different story to tell but mostly the presentations are in the same format, in the same room, and to the same people. So how can you be the one who stands out in the crowd?

Barbara Lavery | May 6, 2010

Biotech